Dafna Capital Management LLC Gamida Cell Ltd. Transaction History

Dafna Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.53 - $3.39 $940,790 - $2.08 Million	614,896 New	614,896 $978,000
Q4 2020 Feb 16, 2021	SELL	$4.07 - $11.0 $569,800 - $1.54 Million	-140,000 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$2.79 - $6.5 $24,498 - $57,076	-8,781 Reduced 5.9%	140,000 $640,000
Q4 2019 Feb 14, 2020	SELL	$4.01 - $5.25 $497,753 - $651,672	-124,128 Reduced 45.48%	148,781 $640,000
Q3 2019 Nov 14, 2019	SELL	$3.0 - $5.09 $6,273 - $10,643	-2,091 Reduced 0.76%	272,909 $1.18 Million
Q2 2019 Aug 14, 2019	BUY	$4.98 - $11.32 $1.37 Million - $3.11 Million	275,000 New	275,000 $1.4 Million

31.4K

Ticker GMDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,319,600
Market Cap $2.29M
Description
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Dafna Capital Management LLC with notifications on news.